<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01652118</url>
  </required_header>
  <id_info>
    <org_study_id>05059079727</org_study_id>
    <nct_id>NCT01652118</nct_id>
  </id_info>
  <brief_title>Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis</brief_title>
  <acronym>Claprum</acronym>
  <official_title>Prophylaxis of Bronchopulmonary Dysplasia With Clarithromycin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine of clarithromycin effect on developing of
      bronchopulmonary dysplasia in preterm babies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators planned that clarithromycin treatment in preterm babies who are under 1250
      grams birth weight.

      The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm
      babies may decrease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bronchopulmonary dysplasia</measure>
    <time_frame>28. day of birth</time_frame>
    <description>On the 28. day of birth, The investigator will determine the baby whether has developed bronchopulmonary dysplasia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of postnatal 40 weeks</time_frame>
    <description>During to hospitalisation the investigator will determine and record some co-morbidities of BPD such as intracranial hemorrhage, necrotizing enterocolitis, patent ductus arteriosus rates.From date of randomization until the end of the hospitalisation up to the 3 months of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>Clarithromycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fist group treated with clarithromycin which is include 10 days application.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Second group treated with salin as same as amount of clarithromycine volume</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clarithromycin treatment for prophylaxis of bronchopulmonary dysplasia</intervention_name>
    <arm_group_label>Clarithromycin</arm_group_label>
    <other_name>Claprum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all infant must be under 1250 gram birth weight

        Exclusion Criteria:

          -  Major congenital anomaly,

          -  CardiaC abnormality,

          -  without inform consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ugur Dilmen, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sadık Yurttutan, M.D</last_name>
    <phone>0905059079727</phone>
    <email>sdkyurttutan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fuat Emre Canpolat, M.D.</last_name>
    <email>femrecan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Middle Anatolia</state>
        <zip>06600</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sadık Yurttutan, M.D</last_name>
      <phone>0905059079727</phone>
    </contact>
    <contact_backup>
      <last_name>Fuat Emre Canpolat, M.D.</last_name>
      <email>femrecan@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sadık Yurttutan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2012</study_first_submitted>
  <study_first_submitted_qc>July 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2012</study_first_posted>
  <last_update_submitted>July 26, 2012</last_update_submitted>
  <last_update_submitted_qc>July 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Sadik Yurttutan</investigator_full_name>
    <investigator_title>Fellowship of neonatology</investigator_title>
  </responsible_party>
  <keyword>bronchopulmonary dysplasia</keyword>
  <keyword>clarithromycin</keyword>
  <keyword>preterm babies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clarithromycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

